# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Primary Progressive Aphasia
- **MONDO ID:**  (if available)
- **Category:** Neurodegenerative Disease

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Primary Progressive Aphasia**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** falcon
**Generated:** 2026-01-31T14:36:02.584836

1. sung2024progranulinhaploinsufficiencymediates pages 1-2
2. tetzloff2023amyloidandtau pages 1-3
3. hsiaonakamoto2024alterationsinlysosomal pages 1-5
4. mirbod2024fdgpetinthe pages 1-2
5. shir2024clinicoradiologicalandneuropathological pages 1-2
6. watanabe2024primaryprogressiveaphasia pages 1-2
7. sevigny2024progranulinaavgene pages 1-2
8. shir2024clinicoradiologicalandneuropathological pages 8-10
9. shir2024clinicoradiologicalandneuropathological pages 4-6
10. shir2024clinicoradiologicalandneuropathological pages 10-11
11. hsiaonakamoto2024alterationsinlysosomal pages 27-30
12. hsiaonakamoto2024alterationsinlysosomal pages 38-41
13. 18F
14. pure-LPA, Wernicke-like, TCSA-like
15. https://doi.org/10.1136/jnnp-2023-332862,
16. https://doi.org/10.1212/WNL.0000000000209924,
17. https://doi.org/10.1007/s12149-024-01958-w,
18. https://doi.org/10.1186/s12974-024-03039-1,
19. https://doi.org/10.1101/2024.02.09.579529,
20. https://doi.org/10.1212/WNL.0000000000201403,
21. https://doi.org/10.1007/s00401-024-02834-7,
22. https://doi.org/10.3233/JAD-230912,
23. https://doi.org/10.1038/s41591-024-02973-0,
24. https://doi.org/10.1136/jnnp-2023-332862;
25. https://doi.org/10.1007/s12149-024-01958-w
26. https://doi.org/10.1007/s12149-024-01958-w;
27. https://doi.org/10.3233/JAD-230912
28. https://doi.org/10.1212/WNL.0000000000209924;
29. https://doi.org/10.1136/jnnp-2023-332862
30. https://doi.org/10.1212/WNL.0000000000209924
31. https://doi.org/10.1212/WNL.0000000000201403
32. https://doi.org/10.1186/s12974-024-03039-1
33. https://doi.org/10.1101/2024.02.09.579529
34. https://doi.org/10.1038/s41591-024-02973-0
35. https://doi.org/10.1212/wnl.0000000000209924,
36. https://doi.org/10.3233/jad-230912,